These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Adverse effects of non-steroidal anti-inflammatory drugs. A prevalence study in Austria]. Kolarz G, Mayrhofer F, Neumann K, Singer F. Wien Klin Wochenschr; 2003 Jan 31; 115(1-2):41-6. PubMed ID: 12658910 [Abstract] [Full Text] [Related]
23. Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. Dutch MJ. Med J Aust; 2008 Jan 07; 188(1):56-7. PubMed ID: 18205567 [Abstract] [Full Text] [Related]
24. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Savage RL, Moller PW, Ballantyne CL, Wells JE. Arthritis Rheum; 1993 Jan 07; 36(1):84-90. PubMed ID: 8424842 [Abstract] [Full Text] [Related]
25. Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer. Christensen S, Riis A, Nørgaard M, Thomsen RW, Sørensen HT. Aliment Pharmacol Ther; 2007 Apr 15; 25(8):907-12. PubMed ID: 17402994 [Abstract] [Full Text] [Related]
26. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Voutilainen M, Mäntynen T, Färkkilä M, Juhola M, Sipponen P. Scand J Gastroenterol; 2001 Aug 15; 36(8):817-21. PubMed ID: 11495076 [Abstract] [Full Text] [Related]
27. Diabetes and 30-day mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort study. Thomsen RW, Riis A, Christensen S, Nørgaard M, Sørensen HT. Diabetes Care; 2006 Apr 15; 29(4):805-10. PubMed ID: 16567819 [Abstract] [Full Text] [Related]
28. Perforated peptic ulcer in southeastern Taiwan. Li CH, Chang WH, Shih SC, Lin SC, Bair MJ. J Gastroenterol Hepatol; 2010 Sep 15; 25(9):1530-6. PubMed ID: 20796151 [Abstract] [Full Text] [Related]
29. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Gisbert JP, Legido J, García-Sanz I, Pajares JM. Dig Liver Dis; 2004 Feb 15; 36(2):116-20. PubMed ID: 15002818 [Abstract] [Full Text] [Related]
30. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis. Steen KS, Lems WF, Aertsen J, Bezemer D, Dijkmans BA. Ann Rheum Dis; 2001 May 15; 60(5):443-7. PubMed ID: 11302864 [Abstract] [Full Text] [Related]
31. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Am J Gastroenterol; 2006 May 15; 101(5):945-53. PubMed ID: 16573778 [Abstract] [Full Text] [Related]
32. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis? Goldstein JL. Eur J Gastroenterol Hepatol; 2000 Jun 15; 12 Suppl 1():S11-5. PubMed ID: 10929893 [Abstract] [Full Text] [Related]
33. Underutilization of preventive strategies in patients receiving NSAIDs. Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL. Rheumatology (Oxford); 2003 Nov 15; 42 Suppl 3():iii23-31. PubMed ID: 14585915 [Abstract] [Full Text] [Related]
34. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Arch Intern Med; 1993 Jul 26; 153(14):1665-70. PubMed ID: 8333804 [Abstract] [Full Text] [Related]
35. Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making. Hansen JM, Hallas J, Lauritsen JM, Bytzer P. Scand J Gastroenterol; 1996 Feb 26; 31(2):126-30. PubMed ID: 8658033 [Abstract] [Full Text] [Related]
36. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders. La Corte R, Caselli M, Castellino G, Bajocchi G, Trotta F. Drug Saf; 1999 Jun 26; 20(6):527-43. PubMed ID: 10392669 [Abstract] [Full Text] [Related]
37. Emergency gastric ulcer complications in elderly. Factors affecting the morbidity and mortality in relation to therapeutic approaches. Di Carlo I, Toro A, Sparatore F, Primo S, Barbagallo F, Di Blasi M. Minerva Chir; 2006 Aug 26; 61(4):325-32. PubMed ID: 17122765 [Abstract] [Full Text] [Related]
38. [Duodenal ulcers, gastric ulcers and Helicobacter pylori]. Dovjak P. Z Gerontol Geriatr; 2017 Feb 26; 50(2):159-169. PubMed ID: 28150170 [Abstract] [Full Text] [Related]
39. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs. Taha AS, Angerson WJ, Prasad R, McCloskey C, Gilmour D, Morran CG. Aliment Pharmacol Ther; 2008 Oct 01; 28(7):878-85. PubMed ID: 18644010 [Abstract] [Full Text] [Related]
40. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan. Ishikawa S, Inaba T, Mizuno M, Okada H, Kuwaki K, Kuzume T, Yokota H, Fukuda Y, Takeda K, Nagano H, Wato M, Kawai K. Acta Med Okayama; 2008 Feb 01; 62(1):29-36. PubMed ID: 18323869 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]